Solstein Capital’s Bruker BRKR Stock Holding History

Solstein Capital’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-140	Closed	-$5.77K	–	457
2025 Q2	$5.77K	Hold	140	–	–	﹤0.01%	384
2025 Q1	$5.84K	Hold	140	–	–	﹤0.01%	265
2024 Q4	$8.21K	Hold	140	–	–	﹤0.01%	249
2024 Q3	$9.67K	Hold	140	–	–	0.01%	244
2024 Q2	$8.93K	Hold	140	–	–	0.01%	242
2024 Q1	$13.2K	Hold	140	–	–	0.01%	226
2023 Q4	$10.3K	Hold	140	–	–	0.01%	238
2023 Q3	$8.72K	Hold	140	–	–	0.01%	237
2023 Q2	$10.3K	Hold	140	–	–	0.01%	228
2023 Q1	$11K	Hold	140	–	–	0.01%	200
2022 Q4	$9.57K	Hold	140	–	–	0.01%	216
2022 Q3	$7K	Hold	140	–	–	0.01%	244
2022 Q2	$9K	Hold	140	–	–	0.01%	262
2022 Q1	$9K	Hold	140	–	–	0.01%	297
2021 Q4	$12K	Hold	140	–	–	0.01%	312
2021 Q3	$11K	Hold	140	–	–	0.01%	349
2021 Q2	$11K	Hold	140	–	–	0.01%	324
2021 Q1	$9K	Buy	+140	New	+$8.41K	0.01%	302

Other funds holding BRKR

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

Solstein Capital's BRKR Position: Q3 2025 in Review

Solstein Capital sold out of Bruker (BRKR) in Q3 2025, closing a stake of 140 shares — an estimated $5.77K sold.

Solstein Capital first reported a position in BRKR in Q1 2021 and held it in 18 quarters. The position peaked at $13.2K in Q1 2024. 340 funds tracked by Wall St. Rank hold BRKR as of Q3 2025.

Solstein Capital reported no remaining Bruker position as of Q3 2025 after selling out during the quarter.
Solstein Capital sold 140 Bruker shares in Q3 2025, an estimated $5.77K.
Solstein Capital first reported a position in Bruker in Q1 2021 and held it in 18 quarters.
Solstein Capital's Bruker position peaked at $13.2K in Q1 2024.
340 funds tracked by Wall St. Rank held Bruker as of Q3 2025.

Based on Solstein Capital's 13F filing for Q3 2025, filed 12 Nov 2025.